Wall Street Access Asset Management, LLC Bristol Myers Squibb CO Transaction History

Wall Street Access Asset Management, LLC

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 09, 2024	BUY	$47.98 - $54.4 $45,581 - $51,680	950 Added 13.9%	7,783 $422,000
Q4 2023 Apr 25, 2024	SELL	$48.48 - $57.85 $72,720 - $86,775	-1,500 Reduced 18.0%	6,833 $350,000
Q4 2023 Feb 13, 2024	SELL	$48.48 - $57.85 $72,720 - $86,775	-1,500 Reduced 18.0%	6,833 $350,000
Q3 2023 Apr 25, 2024	SELL	$57.89 - $64.73 $28,945 - $32,365	-500 Reduced 5.66%	8,333 $483,000
Q3 2023 Nov 06, 2023	SELL	$57.89 - $64.73 $28,945 - $32,365	-500 Reduced 5.66%	8,333 $483,000
Q2 2023 Apr 25, 2024	BUY	$63.71 - $70.74 $50,968 - $56,591	800 Added 9.96%	8,833 $564,000
Q2 2023 Oct 20, 2023	BUY	$63.71 - $70.74 $562,750 - $624,846	8,833 New	8,833 $564,000
Q1 2023 Apr 25, 2024	BUY	$65.71 - $74.53 $210,271 - $238,496	3,200 Added 66.21%	8,033 $556,000
Q1 2023 May 11, 2023	BUY	$65.71 - $74.53 $210,271 - $238,496	3,200 Added 66.21%	8,033 $556,000
Q4 2022 Apr 25, 2024	SELL	$68.48 - $81.09 $136,960 - $162,180	-2,000 Reduced 29.27%	4,833 $347,000
Q4 2021 Feb 15, 2022	BUY	$53.63 - $62.52 $259,193 - $302,159	4,833 New	4,833 $301,000
Q3 2021 Nov 15, 2021	SELL	$59.17 - $69.31 $305,198 - $357,500	-5,158 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$61.91 - $67.42 $92,865 - $101,130	-1,500 Reduced 22.53%	5,158 $344,000
Q1 2021 May 13, 2021	BUY	$59.34 - $66.74 $89,010 - $100,109	1,500 Added 29.08%	6,658 $420,000
Q4 2020 Feb 12, 2021	BUY	$57.74 - $65.43 $297,822 - $337,487	5,158 New	5,158 $319,000

2,533

1.47B

31.6M

35M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $124B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Wall Street Access Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Wall Street Access Asset Management, LLC with notifications on news.